Literature DB >> 19454464

Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

R Glynne-Jones1, J Northover, J Oliveira.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19454464     DOI： 10.1093/annonc/mdp129

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up.

Authors:  Jyoti Parikh; Aidan Shaw; Lee A Grant; Alexis M P Schizas; Vivek Datta; Andrew B Williams; Nyree Griffin
Journal:  Eur Radiol       Date:  2010-10-03       Impact factor: 5.315

2.  Atypical pelvic recurrence of anal squamous cell carcinoma: successful endoscopic ultrasound-guided fine-needle aspiration through the sigmoid colon.

Authors:  Teresa Pinto-Pais; Sónia Sousa-Fermandes; José Manuel Pontes; Luísa Proença; Carlos Fernandes; Iolanda Ribeiro; Ana Paula Costa; Helder Rodrigues; João Carvalho; José Fraga
Journal:  Int J Colorectal Dis       Date:  2014-07-06       Impact factor: 2.571

Review 3.  The differential diagnosis and interdisciplinary treatment of anal carcinoma.

Authors:  Dimitrios Raptis; Ignaz Schneider; Klaus E Matzel; Oliver Ott; Rainer Fietkau; Werner Hohenberger
Journal:  Dtsch Arztebl Int       Date:  2015-04-03       Impact factor: 5.594

4.  The role of MRI in the assessment of the local status of anal carcinomas and in their management.

Authors:  É Jederán; J Lővey; Z Szentirmai; E Hitre; G Léránt; K Horváth; M Gődény
Journal:  Pathol Oncol Res       Date:  2014-10-30       Impact factor: 3.201

5.  No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy.

Authors:  Alexandra K Walker; Christiana Kartsonaki; Elena Collantes; Judith Nicholson; Duncan C Gilbert; Anne E Kiltie
Journal:  Br J Cancer       Date:  2017-06-22       Impact factor: 7.640

Review 6.  Management of persistent anal canal carcinoma after combined-modality therapy: a clinical review.

Authors:  Daniela Musio; Francesca De Felice; Nicola Raffetto; Vincenzo Tombolini
Journal:  Radiat Oncol       Date:  2014-01-28       Impact factor: 3.481
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.